Find a Doctor

Russell D. Cohen

The University Of Chicago Medical Center
Gastroenterology, Internal Medicine
Male
Practicing approx. 31 years

Bio


Russell Cohen is a Gastroenterologist and an Internal Medicine specialist in Chicago, Illinois. He has been an author on 97 peer reviewed articles in the past 15 years. He is licensed to treat patients in IL.

Contact

5841 S Maryland Ave
Chicago, IL 60637, US

Latest Advances


Latest Advance
Study
  • Condition: Severe Steroid Refractory Ulcerative Colitis
  • Journal: Alimentary pharmacology & therapeutics
  • Treatment Used: Calcineurin Inhibitors followed by Vedolizumab Maintenance
  • Number of Patients: 71
  • Published —
This study tested the safety and efficacy of using calcineurin inhibitors followed by vedolizumab maintenance to treat patients with severe steroid refractory ulcerative colitis.
Latest Advance
Study
  • Condition: Ulcerative Colitis and Crohn's Disease
  • Journal: Journal of Crohn's & colitis
  • Treatment Used: Vedolizumab
  • Number of Patients: 32752
  • Published —
This analysis provided safety data on vedolizumab after 4 years in patients with moderate-to-severe ulcerative colitis and Crohn's disease in adults.
Latest Advance
Study
  • Condition: Chronic Antibiotic-Refractory Pouchitis
  • Journal: Digestive diseases and sciences
  • Treatment Used: Ustekinumab
  • Number of Patients: 24
  • Published —
This study investigated the effectiveness of ustekinumab in the treatment of chronic antibiotic-refractory pouchitis.
Latest Advance
Study
  • Condition: Inflammatory Bowel Diseases
  • Journal: Journal of gastroenterology and hepatology
  • Treatment Used: Vedolizumab
  • Number of Patients: 41
  • Published —
In this study, researchers evaluated the safety and effectiveness of switching to vedolizumab from anti-TNF agents for the treatment of inflammatory bowel disease.
Latest Advance
Study
  • Condition: Crohn's Disease
  • Journal: Journal of Crohn's & colitis
  • Treatment Used: Low-Dose Metronidazole
  • Number of Patients: 70
  • Published —
In this study, researchers evaluated the outcomes of taking low-dose metronidazole for 3 months in order to prevent recurrence of Crohn's disease after surgery.
Latest Advance
Study
  • Condition: Post-Infliximab Failure in Hospitalized Patients With Acute Severe Colitis (ASC)
  • Journal: Journal of Crohn's & colitis
  • Treatment Used: Ciclosporin Therapy
  • Number of Patients: 40
  • Published —
This study investigated the effectiveness and safety of ciclosporin in patients with steroid-refractory acute severe colitis (ASC) failing first-line rescue therapy with infliximab.
Latest Advance
Study
  • Condition: Crohn's Disease and Ulcerative Colitis
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Calcineurin Inhibitors and Vedolizumab
  • Number of Patients: 20
  • Published —
In this study, researchers evaluated the safety and effectiveness of treating Crohn's disease and ulcerative colitis with calcineurin inhibitors and vedolizumab.
Latest Advance
Study
  • Condition: Inflammatory Bowel Disease
  • Journal: Inflammatory bowel diseases
  • Treatment Used: Vedolizumab as Induction and Maintenance
  • Number of Patients: 132
  • Published —
This study examined the effectiveness and safety of vedolizumab in inflammatory bowel disease.
Latest Advance
Study
  • Condition: Crohn's Disease
  • Journal: Inflammatory bowel diseases
  • Treatment Used: infliximab
  • Number of Patients: 6273
  • Published —
This longitudinal observational study evaluated the effects of inflixumab in patients with Crohn's disease (CD).
Latest Advance
Study
  • Condition: Preventing Postoperative Recurrence of Crohn's Disease (CD)
  • Journal: Inflammatory bowel diseases
  • Treatment Used: Vedolizumab
  • Number of Patients: 203
  • Published —
This study investigated the use of vedolizumab in the postoperative setting and compare the risk of recurrence between patients with Crohn's disease receiving vedolizumab and anti-tumor necrosis factor (TNF)-? agents.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Conference
  • Sponsor: American College of Gastroenterology (ACG)
  • Event Name: American College of Gastroenterology Annual Meeting 2020
  • Published —
Evaluating Cost Per Remission and Cost of Serious Adverse Events in Advanced Therapies for Ulcerative Colitis
Publication
Conference
  • Sponsor: American College of Gastroenterology (ACG)
  • Event Name: American College of Gastroenterology Annual Meeting 2020
  • Published —
The Transition of the J-Pouch Phenotype in Inflammatory Bowel Disease Patients With Cuffitis

Contact

5841 S Maryland Ave
Chicago, IL 60637, US

Affiliations

  • The University Of Chicago Medical Center
  • Ingalls Memorial Hospital

Credentials

  • Graduate InstitutionIcahn School Of Medicine At Mount Sinai
    1990
  • Licenses
    Internal Medicine in IL
  • Board Certifications
    Gastroenterology
    Internal Medicine

Insurance

Contact them to find out if they accept your insurance plan.